Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Outset Medical, Inc. - Common Stock (NQ:OM)

4.965 -0.575 (-10.38%)
Streaming Delayed Price Updated: 3:48 PM EST, Nov 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Outset Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Stocks Peddle Backwards as Dow Sheds Triple Digits ↗
Stocks have given up their morning gains at midday. 
Via Talk Markets
News headline image
Analyst Ratings for Outset Medical ↗
Over the past 3 months, 4 analysts have published their opinion on Outset Medical (NASDAQ:OM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
Mid-Day Market Update: Dow Turns Lower; Qudian Shares Surge ↗
U.S. stocks pared gains midway through trading, with the Dow Jones and S&P 500 turning lower on Tuesday. 
Via Benzinga
News headline image
41 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Revlon, Inc. (NYSE: REV) rose 125.5% to $2.6499. Revlon’s stock dropped sharply on Monday after the company is reportedly expected to file for bankruptcy. 
Via Benzinga
News headline image
Why Outset Medical Shares Are Trading Lower Today ↗
 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Open Higher; US Producer Prices Increase 0.8% In May ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining by more than 100 points on Tuesday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
Outset Medical Earnings Perspective: Return On Capital Employed ↗
According to data from Benzinga Pro, during Q1, Outset Medical's (NASDAQ:OM) reported sales totaled $30.55 million. Despite a 10.53% increase in earnings, the company posted a loss of $36.89 million. 
Via Benzinga
News headline image
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel... 
Via Benzinga
News headline image
Outset Medical More Than Doubles Sales In FY21, Issues Better Than Expected FY22 Outlook ↗
 
Via Benzinga
News headline image
110 Biggest Movers From Friday ↗
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital. 
Via Benzinga
News headline image
Recap: Outset Medical Q4 Earnings ↗
  Outset Medical (NASDAQ:OM) reported its Q4 earnings results on Wednesday, February 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Earnings Scheduled For February 16, 2022 ↗
Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is projected to report quarterly loss at $0.38 per share on revenue of $331.16 million. 
Via Benzinga
News headline image
83 Biggest Movers From Yesterday ↗
Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results. 
Via Benzinga
News headline image
57 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following... 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Inspirato Incorporated (NASDAQ: ISPO) shares climbed 618.2% to close at $92.65 on Thursday, just a few days after the company completed its SPAC merger with Thayer... 
Via Benzinga
News headline image
Earnings Preview For Outset Medical ↗
Outset Medical (NASDAQ:OM) is set to give its latest quarterly earnings report on Wednesday, 2022-02-16. Here's what investors need to know before the announcement. Analysts estimate that Outset... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-... 
Via Benzinga
News headline image
Outset Medical's Tablo Hemodialysis System Cartridge Receives FDA Approval For Manufacturing In North America ↗
The FDA has granted 510(k) clearance for Outset Medical Inc's (NASDAQ: OM) new sterilization method of the cartridge utilized in its Tablo Hemodialysis... 
Via Benzinga
News headline image
Outset Medical Inc (OM) Q3 2021 Earnings Call Transcript ↗
OM earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics... 
Via Benzinga
Topics Retirement
News headline image
Outset Medical's Return On Capital Employed Insights ↗
Outset Medical (NASDAQ:OM) brought in sales totaling $25.22 million during Q2 according to data provided by Benzinga Pro.However, earnings decreased 0.78%, resulting in a loss of... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
News headline image
1 Beaten-Down Healthcare Stock to Put on Your Radar ↗
This innovative company is well off its highs and could be worth a look. 
Via The Motley Fool
News headline image
2 Beaten Down Stocks With 10X Potential ↗
While there's no way to accurately predict the future, these stocks have a chance to produce tremendous returns if things go well. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2021 ↗
Upgrades According to Oppenheimer, the prior rating for The Wendy's Co (NASDAQ: 
Via Benzinga
News headline image
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.